HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Groeger, A. M. Articles by Wolner, E. Search for Related Content PubMed PubMed Citation Articles by Groeger, A. M. Articles by Wolner, E.

European Journal of Cardio-Thoracic Surgery, Vol 12, 703-705, Copyright © 1997 by European Association for Cardio-thoracic Surgery

ARTICLES

Survival after surgical treatment of recurrent pulmonary metastases

AM Groeger, D Kandioler, MR Mueller, A End, F Eckersberger and E Wolner
Department of Cardio-Thoracic Surgery, University of Vienna, Austria.

OBJECTIVE: Resection of lung metastases is a generally accepted therapeutic strategy today. This retrospective study was performed in order to estimate the value of an aggressive surgical approach in recurrent metastatic disease of the lung. METHODS: The survival rates of 42 patients undergoing repeated resectional treatment for recurrent lung metastases (group A) were compared to the outcome of a total of 288 patients after a single surgical intervention for lung metastases (group B). Survival rates and the relative effects of the various prognostic factors were calculated according to Kaplan-Maier and Mantel Cox or Wilcoxon test. Histology of the primary tumors in group A consisted of 18 carcinomas, 22 sarcomas and two melanomas, in group B the distribution was 64% carcinoma, 27% sarcoma and 9% melanoma. The mean follow-up period was 88.5 months for group A and 27 months for group B. RESULTS: The overall survival rate for group A was 48% at 5 years and 30% at 10 years, the survival rate for group B was 34% at 5 years. CONCLUSION: Long-term survival rates superior to those after single resectional treatment for lung metastases encourage an aggressive surgical approach for this disease.

This article has been cited by other articles:

				J. Nakajima, T. Murakawa, T. Fukami, and S. Takamoto Is thoracoscopic surgery justified to treat pulmonary metastasis from colorectal cancer? Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 212 - 217. [Abstract] [Full Text] [PDF]

				S. Welter, J. Jacobs, T. Krbek, B. Krebs, and G. Stamatis Long-Term Survival After Repeated Resection of Pulmonary Metastases From Colorectal Cancer Ann. Thorac. Surg., July 1, 2007; 84(1): 203 - 210. [Abstract] [Full Text] [PDF]

				M. Higashiyama, K. Kodama, K. Takami, N. Higaki, H. Yokouchi, T. Nakayama, K. Murata, M. Kameyama, J.-i. Ashimura, Y. Naruse, et al. Intraoperative Lavage Cytologic Analysis of Surgical Margins as a Predictor of Local Recurrence in Pulmonary Metastasectomy Arch Surg, April 1, 2002; 137(4): 469 - 474. [Abstract] [Full Text] [PDF]